India is set to launch its first indigenously developed Quadrivalent Human Papillomavirus Vaccine (qHPV) against Cervical cancer with the help of the Serum Institute of India (SII) and the Department of Biotechnology (DBT) on 1st September 2022. The vaccine for Cervical cancer “CERVAVAC”, will be launched by Union Minister of State Science and Technology Jitendra Singh. The vaccine is likely to cost around 200-400 per dose.
Bank Maha Pack includes Live Batches, Test Series, Video Lectures & eBooks
As per the government data, cervical cancer ranks number 2 for most prevalent cancer in India and also accounts for one-fourth of the world’s cervical cancer deaths. Approximately 1.25 lakhs women are diagnosed with Cervical cancer and over 75 thousand females die from the disease in India. The Union government plans to target the age of 9-14 years of girls for vaccination against cervical cancer. Before the rollout of the vaccine, a sensitization program will be organized by the government to educate parents and school authorities. The government also said that CERVAVAC is an outcome of the partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation.
India's Anahat Singh has won for the first time ever the World Junior Squash title…
Sarnath, an ancient Buddhist site located in Uttar Pradesh, made it to the UNESCO World…
India’s star weightlifter Mirabai Chanu has won the gold medal in the women’s 48kg category…
Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…
Kargil Vijay Diwas is celebrated on July 26, every year in India in remembrance of…
Pralhad Joshi, a cabinet minister in the Union Government, has been given the additional responsibility…